BMC Cancer is an open access, peer-reviewed journal that considers articles on all 2002 2005 2008 2011 2014 2017 Cancer Research Genetics Oncology.

BMC Public Health is committed to playing a role in advancing progress towards achieving the Sustainable Development Goals (SDGs), including SDG3, by supporting researchers in disseminating their related work and showcasing this to assist policy-makers, governments and humanitarian organizations in making research-backed decisions to advance the international well-being agenda.

Breast Cancer Research therefore levies an article-processing charge of £2380.00/$3380.00/€2790.00 for each article accepted for publication, plus VAT or local taxes where applicable. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page ). If you review for a journal in the BMC Series then you are entitled to a 15% discount on the article processing charge for your next submission to the BMC Series. This discount must be claimed within 1 year of completing your review and discounts cannot be combined.

Click on a pathway for a more detailed view. 5 Mar 2007 BMC Cancer 2007, 7:39 doi:10.1186/1471-2407-7-39 with specific bioclinical features including a low rate of Pre-publication history. 9 Jan 2006 BMC Cancer 2006, 6:6 doi:10.1186/1471-2407-6-6 X-ray source at a dose rate of 0.77 Gy/min. Publish with Bio Med Central and every.

Publication Fee BMC Cancer is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Open Access allows taxpayers to see the results of their investment.

Breast Cancer Research therefore levies an article-processing charge of £2380.00/$3380.00/€2790.00 for each article accepted for publication, plus VAT or local taxes where applicable. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page ). BMC Cancer 1471-2407 (Online) DOAJ Seal Website ISSN Portal About; Articles; About. Publishing with this journal.

BMC Cancer Transparent peer review; BMC Immunology; BMC Weibo page; By using this website, you agree to our Terms and Conditions

The APC, payable when your manuscript is editorially accepted and before publication, is charged to either you, or your funder, institution or employer. APCs vary by journal; visit our journal pages for individual journal fees.

Open access publishing is not without costs.
Liljekvist laholm jobb

The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Publication Fee BMC Cancer is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction.
Omformulera meningar online

20 Jul 2010 Open Access pathways permitted by this journal's policy are listed below by article version. Click on a pathway for a more detailed view.

BMC Weibo page By using this website, you agree to our Terms and Conditions , California Privacy Statement , Privacy statement and Cookies policy. BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service. BMC Cancer is a peer-reviewed open access medical journal that publishes original research on cancer and oncology. It was established in 2001 and is published by BioMed Central. Abstracting and indexing. The journal is abstracted and indexed by PubMed, MEDLINE, CAS, EMBASE, Scopus, Current Contents, and CABI.